KoBIA (사단법인 한국바이오의약품협회)
Business Registration No.: 1018220514 | Unlisted Corporate Supplier
| English Name (KONEPS / DART) | KoBIA |
|---|---|
| Korean Legal Name | 사단법인 한국바이오의약품협회 |
| Business Registration No. | 1018220514 |
| Established Date | 2011-05-17 |
| Region | 서울특별시 강남구 |
| Address (KO) | 서울특별시 강남구 테헤란로78길 12, 3층(대치동, MSA빌딩) |
| Homepage | http://www.kobia.kr/ |
| Manufacturer Classification | supplier (공급) |
| Reported Employees | 22 (Self-reported employee count at Korea ON-Line E-Procurement System (KONEPS) registration; may differ from National Pension Service (L1) subscriber counts.) |
| source_url | https://www.g2b.go.kr |
| verified_at | 2026-11-02T04:36:11.608Z |
Public procurement (last 12 months)
Contracts first signed in the last 12 months.
The 12-month window is by original contract signing date: it covers contracts first signed in the period, and excludes amendments registered in the period to contracts signed earlier. Amounts are in KRW from Korea's Public Procurement Service (KONEPS). The 12-month total counts sole contracts in full and joint contracts by the supplier's share; joint contracts without a published share are counted but not summed. Multi-year contracts count only the current-period amount. Unit-price (framework) contracts are reported separately because their values are ceilings, not spend.
| Aggregation Period | 2025-11-01 to 2026-10-31 (basis: original_signed_date) |
|---|---|
| 12-Month Procurement Amount | KRW 2,169,377,300 |
| 12-Month Contract Count | 16 (Joint contracts: 3) |
| Unit-Price (Framework) Contracts (Reported Separately) | 0 contracts | Ceiling: KRW 0 |
| Procurement Source | https://www.g2b.go.kr (verified: 2026-11-02T04:36:11.608Z) |
By Procurement Category
| Category | Contracts | 12M Counted Amount (KRW) |
|---|---|---|
| Goods (물품) | 0 | KRW 0 |
| Construction (공사) | 0 | KRW 0 |
| Services (용역) | 16 | KRW 2,169,377,300 |
| Foreign Procurement (외자) | 0 | KRW 0 |
By Contract Type
| Contract Type | Contracts | Supplier Share / Current Amount (KRW) | Total Contract Ceiling / Multi-year Total (KRW) |
|---|---|---|---|
| Lump-sum / Standard (총액·일반) | 16 | KRW 2,169,377,300 | KRW 673,060,000 |
| Multi-year / Continuing (장기·계속비) | 0 | KRW 0 | KRW 0 |
| Unit-price / Framework Ceiling (단가·제3자단가 — excluded from 12M total) | 0 | KRW 0 | KRW 0 |
| Unclassified / Zero-amount (기타) | 0 | KRW 0 | KRW 0 |
Top 5 Government Buyers
| Buyer (Korean Legal Name) | Agency Code | Contracts | 12M Amount (KRW) |
|---|---|---|---|
| 식품의약품안전처 식품의약품안전평가원 | 1471057 | 4 | KRW 1,271,567,300 |
| 식품의약품안전처 | 1471000 | 8 | KRW 623,810,000 |
| 한국보건산업진흥원 | B551174 | 2 | KRW 149,000,000 |
| 백신안전기술지원센터 | Z041500 | 2 | KRW 125,000,000 |
Recent Contracts (up to 16)
| Signed Date | Contract No. (KONEPS) | Contract Title (KO) | Category / Type | Buyer (KO) | Contract Amount (KRW) | Participation |
|---|---|---|---|---|---|---|
2026-09-23 |
R26TA02260747 |
2026 글로벌 규제·시장 변화에 따른 백신안전기술지원센터 전주기 지원 용역 | services / lump_sum |
백신안전기술지원센터 | KRW 105,000,000 |
Sole (100%) |
2026-08-27 |
R26TA02182078 |
GBC 2026 바이오의약품 동물대체시험법 워크숍 | services / lump_sum |
백신안전기술지원센터 | KRW 20,000,000 |
Sole (100%) |
2026-07-20 |
R26TA02066950 |
2026년 국내·외 임상시험 초청 강연 및 교육 운영 | services / lump_sum |
식품의약품안전처 | KRW 31,360,000 |
Sole (100%) |
2026-06-15 |
R26TA01959368 |
항체-약물접합체(ADC) 선제적 규제지원 체계 마련 연구 | services / lump_sum |
식품의약품안전처 식품의약품안전평가원 | KRW 49,800,000 |
Joint (70%) |
2026-06-05 |
R26TA01936422 |
2026년도 바이오의약품 GMP 교육 | services / lump_sum |
식품의약품안전처 | KRW 93,000,000 |
Sole (100%) |
2026-05-26 |
R26TA01899109 |
GMP 협력 기반 확대를 위한 현황 분석 및 추진 전략 마련 연구 | services / lump_sum |
식품의약품안전처 | KRW 56,900,000 |
Sole (100%) |
2026-05-26 |
R26TA01866458 |
2026년도 백신 및 바이오시밀러 WHO 품질인증(PQ) 지원 사업 | services / lump_sum |
식품의약품안전처 | KRW 29,400,000 |
Sole (100%) |
2026-05-21 |
R26TA01870365 |
오가노이드 국내 산업 진단 및 성장 전략 수립 | services / lump_sum |
한국보건산업진흥원 | KRW 60,000,000 |
Sole (100%) |
2026-05-21 |
R26TA01828671 |
바이오의약품 원료물질 인증 지원 사업 | services / lump_sum |
식품의약품안전처 | KRW 79,000,000 |
Joint (45%) |
2026-05-06 |
R26TA01807883 |
2026년 첨단 신기술 기반 바이오의약품 가이드라인 개발 | services / lump_sum |
식품의약품안전처 식품의약품안전평가원 | KRW 2,320,141,090 |
Joint (47.7%) |
2026-04-29 |
R26TA01811586 |
2026년도 바이오의약품분야 통계조사 사업 | services / lump_sum |
식품의약품안전처 | KRW 20,000,000 |
Sole (100%) |
2026-04-15 |
R26TA01743451 |
글로벌 규제조화센터 2026년도 ICH 가이드라인 교육 운영 | services / lump_sum |
식품의약품안전처 식품의약품안전평가원 | KRW 110,000,000 |
Sole (100%) |
2026-04-13 |
R26TA01742448 |
백신 산업체 정보교류를 위한 국내외 산업 및 정책 정보 조사 | services / lump_sum |
한국보건산업진흥원 | KRW 89,000,000 |
Sole (100%) |
2026-03-23 |
R26TA01645536 |
2026년 바이오의약품 해외진출 종합지원 사업 | services / lump_sum |
식품의약품안전처 | KRW 338,000,000 |
Sole (100%) |
2026-02-11 |
R26TA01440077 |
2026년도 임상시험 GCP 조사관 역량강화교육 위탁용역 | services / lump_sum |
식품의약품안전처 | KRW 19,600,000 |
Sole (100%) |
2025-11-11 |
R25TA01069017 |
생물학적제제 일반시험법 전문가 감수 기술 용역 | services / lump_sum |
식품의약품안전처 식품의약품안전평가원 | KRW 20,000,000 |
Sole (100%) |
Source & Disclaimer
source_url: https://www.g2b.go.kr | verified_at: 2026-11-02T04:36:11.608Z
Data from Korea's Public Procurement Service (KONEPS contract and supplier records) via data.go.kr. Corporate suppliers only; sole proprietors are excluded. Not investment advice.